Background: Chronic hepatitis B (CHB) is a major cause of liver-related morbidity and mortality in the United States (US) and globally. CHB disproportionately affects Asian Americans and many other immigrant minority populations, primarily owing to the high prevalence of CHB in their countries of origin. India is a country with a medium-to-high prevalence of hepatitis B (HB) (>2%) and has over 40 million people infected with hepatitis B virus (HBV), with more than 115,000 deaths annually from HBV-related complications. Indian Americans are one of the largest immigrant populations in the US but remain underdiagnosed and poorly linked to clinical care. We, therefore, assessed the HBV prevalence and evaluated the linkage-to-care (LTC) among Indian Americans to develop strategic plans to reduce the impact of HBV in the US. Methods: Between April 2022 and January 2024, serologic screening and surveys were provided to 328 Indian American adults (age 20 - 80) in New York City. All participants were tested for a triple panel consisting of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core IgG antibody (anti-HBc). A survey was conducted on the subjects chronically infected with HBV regarding their histories of infection. Self-administered questionnaires were employed to evaluate demographic and epidemiologic characteristics. Results: Of 328 screened and evaluated (246 males and 82 females), 10 (3.0%) were HBV-infected, 222 (67.7%) were susceptible to HBV, and 96 (29.3%) were immune. The prevalence of chronic HBV varied between the age groups: 4.6% (age 20 - 40), 3.4% (age 41 - 60), and 1.7% (age 61 - 80). Of 10 chronically infected, only two subjects had been previously diagnosed but were not engaged in care. Conclusion: HBV disproportionately affects Asian Americans, primarily owing to immigration from parts of the world where the disease is endemic. Indian Americans belong to an intermediate-risk group, with an HBV prevalence of >2%, but remain underdiagnosed and poorly linked to care. Our pilot study on Indian American populations, the first of its kind, demonstrates a 3% prevalence of CHB, none of whom are linked to care. In addition, this population has a high percentage of unimmune subjects, creating a large reservoir for future infection. With the growing population of Indian Americans, our findings can be used to develop community-based strategies for
References
[1]
World Health Organization (2016) Elimination of Hepatitis by 2030. https://www.who.int/health-topics/hepatitis/elimination-of-hepatitis-by-2030#tab=tab_1
[2]
World Health Organization (2016) Global Health Sector Strategy on Viral Hepatitis 2016-2021. https://iris.who.int/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1
[3]
Hollinger, F.B. and Liang, T.J. (2001) Hepatitis B Virus. In: Knipe, D.M., et al., Eds., Fields Virology, 4th Edition, Lippincott Williams & Wilkins, Philadelphia, 2971-3036.
[4]
McMahon, B.J. (2010) Natural History of Chronic Hepatitis B. Clinics in Liver Disease, 14, 381-396. https://doi.org/10.1016/j.cld.2010.05.007
[5]
World Health Organization (2023) High-Level Resource Mobilization Conference to Eliminate Viral Hepatitis. https://www.who.int/news/item/17-05-2023-high-level-resource-mobilization-conference-to-eliminate-viral-hepatitis#:~:text=If not addressed, viral hepatitis,is hugely neglected and underfunded
[6]
Wong, R.J., Brosgart, C.L., Welch, S., et al. (2021) An Updated Assessment of Chronic Hepatitis B Prevalence among Foreign-Born Persons Living in the United States. Hepatology, 74, 607-626. https://doi.org/10.1002/hep.31782
[7]
Le, M.H., Yeo, Y.H., Cheung, R., et al. (2020) Chronic Hepatitis B Prevalence among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016. Hepatology, 71, 431-443. https://doi.org/10.1002/hep.30831
[8]
Mitchell, T., Armstrong, G.L., Hu, D.J., et al. (2011) The Increasing Burden of Imported Chronic Hepatitis B—United States, 1974-2008. PLOS ONE, 6, e27717. https://doi.org/10.1371/journal.pone.0027717
[9]
Cohen, C., Evans, A.A., London, W.T., et al. (2008) Underestimation of Chronic Hepatitis B Virus Infection in the United States of America. Journal of Viral Hepatitis, 15, 12-13. https://doi.org/10.1111/j.1365-2893.2007.00888.x
[10]
Cohen, C., Holmberg, S.D., McMahon, B.J., et al. (2011) Is Chronic Hepatitis B Being Undertreated in the United States? Journal of Viral Hepatitis, 18, 377-383. https://doi.org/10.1111/j.1365-2893.2010.01401.x
[11]
Weng, M.K., Doshani, M., Kahn, M.A., et al. (2022) Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022. Morbidity and Mortality Weekly Report, 71, 477-483. https://doi.org/10.15585/mmwr.mm7113a1 https://www.cdc.gov/mmwr/volumes/71/wr/mm7113a1.htm
[12]
LaMori, J., Feng, X., Pericone, C.D., et al. (2022) Hepatitis Vaccination Adherence and Completion Rates and Factors Associated with Low Compliance: A Claims-Based Analysis of U.S. Adults. PLOS ONE, 17, e0264062. https://doi.org/10.1371/journal.pone.0264062
[13]
WHO (2023) Immunization Coverage. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
[14]
Machmud, P.B., Glasauer, S., Gottschick, C., et al. (2021) Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review. Vaccines, 9, Article 625. https://doi.org/10.3390/vaccines9060625
[15]
Hu, K.-Q., Pan, C.Q. and Goodwin, D. (2011) Barriers to Screening for Hepatitis B Virus Infection in Asian Americans. Digestive Diseases and Sciences, 56, 3163-3171. https://doi.org/10.1007/s10620-011-1840-6
[16]
Philbin, M.M., Erby, L.A., Lee, S., et al. (2012) Hepatitis B and Liver Cancer among Three Asian American Sub-Groups: A Focus Group Inquiry. Journal of Immigrant and Minority Health, 14, 858-868. https://doi.org/10.1007/s10903-011-9523-0
[17]
Pollack, H., Wan, K., Miyoshi, T., et al. (2007) Management of Chronic Hepatitis B Virus (HBV) Infection by Primary Care Physicians in Urban Hospitals and Clinics in New York City. Hepatology, 46, 676A.
[18]
Upadhyaya, N., Chang, R., Davis, C., et al. (2010) Chronic Hepatitis B: Perceptions in Asian American Communities and Diagnosis and Management Practices among Primary Care Physicians. Postgraduate Medicine, 122,165-175. https://doi.org/10.3810/pgm.2010.09.2213
[19]
Ferrante, J.M., Winston, D.G., Chen, P.-H., et al. (2013) Family Physicians’ Knowledge and Screening of Chronic Hepatitis and Liver Cancer. Family Medicine, 40, 345-351.
[20]
Cohen, C., Caballero, J., Martin, M., et al. (2013) Eradication of Hepatitis B: A Nationwide Community Coalition Approach to Improving Vaccination, Screening, and Linkage to Care. Journal of Community Health, 38, 799-804. https://doi.org/10.1007/s10900-013-9699-4
[21]
Ward, J.W. and Byrd, K.K. (2012) Hepatitis B in the United States: A Major Health Disparity Affecting Many Foreign-Born Populations. Hepatology, 56, 419-421. https://doi.org/10.1002/hep.25799
[22]
Chen, M.S. and Dang, J. (2015) Hepatitis B among Asian Americans: Prevalence, Progress, and Prospects for Control. World Journal of Gastroenterology, 21, 11924-11930. https://doi.org/10.3748/wjg.v21.i42.11924
[23]
Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., et al. (2006) Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years. Gastroenterology, 131, 1743-1751. https://doi.org/10.1053/j.gastro.2006.09.020
[24]
Haber, P. and Schillie, S. (2016) Hepatitis B. In: Hall, E., Wodi, A.P., Hamborsky, J., Morelli, V. and Schillie, S., Eds., Epidemiology and Prevention of Vaccine-Preventable Diseases,Public Health Foundation, Washington, DC, 143-164. http://www.cdc.gov/vaccines/pubs/pinkbook/hepb.html
[25]
Puri, P. (2014) Tackling the Hepatitis B Disease Burden in India. Journal of Clinical and Experimental Hepatology, 4, 312-319. https://doi.org/10.1016/j.jceh.2014.12.004
[26]
Kumar, A., Arora, A., Sharma, P., et al. (2023) Public Knowledge, Awareness, and Vaccination Rates for Hepatitis B in India: A Cross-Sectional Survey. Cureus, 15, e43997. https://doi.org/10.7759/cureus.43997
[27]
Hoffman, A. and Batalova, A. (2022) Indian Immigrants in the United States. https://www.migrationpolicy.org/article/indian-immigrants-united-states
[28]
Rico, B., Hahn, J.K., Spence, C. and United Census Bureau (2023) Asian Indian Was the Largest Asian Alone Population Group in 2020. https://www.census.gov/library/stories/2023/09/2020-census-dhc-a-asian-populatio n.html
[29]
Hyun, C., Lee, S. and Ventura, W.R. (2019) The Prevalence and Significance of Isolated Hepatitis B Core Antibody (Anti-HBc) in Endemic Population. BMC Research Notes, 12, Article No. 251. https://doi.org/10.1186/s13104-019-4287-z
[30]
Hyun, C., Kim, S., Kang, S.Y., et al. (2016) Chronic Hepatitis B in Korean Americans: Decreased Prevalence and Poor Linkage to Care. BMC Infectious Diseases, 16, Article No. 415. https://doi.org/10.1186/s12879-016-1732-7
[31]
Hyun, C.S., Wang, H., Ko, O., et al. (2021) Hepatitis B Awareness Campaign in Chinese Americans: A Community Outreach Model to Facilitate Screening and Linkage to Care. International Journal of Health Promotion and Education, 59, 366-377. https://doi.org/10.1080/14635240.2021.1964375
[32]
Bhattacharya, H., Parai D., Sahoo, S.K., et al. (2023) Hepatitis B Virus Infection among the Tribal and Particularly Vulnerable Tribal Population from an Eastern State of India: Findings from the Serosurvey in Seven Tribal Dominated Districts, 2021-2022. Frontiers in Microbiology, 14, 1039696. https://doi.org/10.3389/fmicb.2023.1039696
[33]
World Health Organization (2016) WHO Factsheet-b-World Hepatitis Day 2016. https://www.who.int/docs/default-source/searo/india/health-topic-pdf/factsheet-b-hepatitisday2016.pdf?sfvrsn=da61ef0_2
[34]
Kumar, D., Peter, R.M., Joseph, A., et al. (2023) Prevalence of Viral Hepatitis Infection in India: A Systematic Review and Meta-Analysis. Journal of Education and Health Promotion, 12, 103. https://doi.org/10.4103/jehp.jehp_1005_22
[35]
Lok, A.S.F., Lai, C.-L. and Wu, P.-C. (1988) Prevalence of Isolated Antibody to Hepatitis B Core Antigen in an Area Endemic for Hepatitis B Virus Infection: Implications in Hepatitis B Vaccinations Programs. Hepatology,8, 766-770. https://doi.org/10.1002/hep.1840080411
[36]
Wang, X., Zamal, A., Wang, R., et al. (2023) Disparities and Trends in Routine Adult Vaccination Rates among Disaggregated Asian American Subgroups, National Health Interview Survey 2006-2018. AJPM Focus, 2, Article 100044. https://doi.org/10.1016/j.focus.2022.100044
[37]
Murhekar, M.V., Kumar, M.S., Kamaraj, P., et al. (2020). Hepatitis-B Virus Infection in India: Findings from a Nationally Representative Serosurvey, 2017-18. International Journal of Infectious Diseases, 100, 455-460. https://doi.org/10.1016/j.ijid.2020.08.084
[38]
Lahariya, C., Subramanya, B.P. and Sosler, S. (2013) An Assessment of Hepatitis B Vaccine Introduction in India: Lessons for Roll Out and Scale up of New Vaccines in Immunization Programs. Indian Journal of Public Health, 57, 8-14. https://doi.org/10.4103/0019-557X.111357
[39]
Aggarwal, R. and Naik, S.R. (1996) Cost Efficacy Evaluation of Inclusion of Hepatitis-B Vaccine in Expanded Programme of Immunization. In: Sarin, S.K. and Singhal, A.K., Eds., Hepatitis B in India, CBS Publishers and Distributors, New Delhi, 206-216.
[40]
Premkumar, M. and Kumar, C.Y. (2021) Chronic Hepatitis B: Challenges and Successes in India. Clinical Liver Disease, 18, 111-116. https://doi.org/10.1002/cld.1125
[41]
Hyun, C.S., Ko, O., Lee, S. and McMenamin, J. (2019). Long Term Outcome of a Community-Based Hepatitis B Awareness Campaign: Eight-Year Follow-Up on Linkage to Care (LTC) in HBV Infected Individuals. BMC Infectious Diseases, 19, Article No. 638. https://doi.org/10.1186/s12879-019-4283-x
[42]
Harris, A.M., Link-Gelles, R., Kim, K., et al. (2018) Community-Based Services to Improve Testing and Linkage to Care among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection—Three U.S. Programs, October 2014-September 2017. Morbidity and Mortality Weekly Report, 67, 541-546. https://doi.org/10.15585/mmwr.mm6719a2
